Clinical Trial Update: MicroOrganoSphere (MOS) Drug Screen Pilot Trial in Colorectal Cancer

View source ↗

Summary

The pilot trial evaluating Xilis' MicroOrganoSphere Drug Screen in colorectal cancer has completed enrollment/status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• MicroOrganoSphere (MOS) Drug Screen

Snippet

Sponsor: Xilis, Inc. | Conditions: Colorectal Neoplasms | Status: COMPLETED